Paradoxical Roles of Reactive Oxygen Species in Pancreatic Beta-Cell Function
活性氧在胰腺 β 细胞功能中的矛盾作用
基本信息
- 批准号:7643808
- 负责人:
- 金额:$ 8.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AntioxidantsAreaCell physiologyCellsChronicConfocal MicroscopyCoupledDataDefense MechanismsDevelopmentDevelopment PlansDiabetes MellitusDiseaseEnzymesEtiologyEventExhibitsFailureFluorescent ProbesFosteringFunctional disorderFutureGene ExpressionGene TargetingGenerationsGenesGeneticGlucoseGoalsGrantHandHand functionsHormonalHydrogen PeroxideInsulinInterventionKnock-outKnowledgeLeadMeasuresMediatingMediator of activation proteinMetabolicMetabolismMitochondriaModelingMolecularMonitorMusNitric OxideNuclearNutrientOralOxidation-ReductionOxidative PhosphorylationOxidative StressOxidative Stress InductionPancreasPathogenesisPhysiologicalPlayPreventiveProcessProductionReactive Oxygen SpeciesRecombinantsResearchResearch PersonnelResearch Project GrantsResourcesRoleScientistSignal TransductionStructure of beta Cell of isletSuperoxidesSystemTestingTimeUCP2 proteinWritingblood glucose regulationcareercareer developmentcatalasecell injurydesignexperienceglucose metabolismglucose productionglutathione peroxidaseinsightinsulin secretionisletknowledge basemouse modeloverexpressionoxidative damagerelating to nervous systemresearch studyresponsestressortranscription factortreatment strategytype I and type II diabetesvector
项目摘要
DESCRIPTION (provided by applicant):
The long-term goal of Dr. Jingbo Pi is to become a successful independent investigator in the research field of diabetes. The large majority of Dr. Pi's time will be spent on the research project that he has described in his proposal on reactive oxygen species and (-cell function (summarized below in the Project Summary). This experience will provide him with both the theoretical and practical knowledge base upon which to build a career as an independent investigator in this area. The major immediate goals in his career development plan are (i) enrichment of his knowledge and research experience in the field of diabetes; (ii) develop excellence in scientific presentation, both oral and written; and (iii) grantsmanship and how to best organize the necessary resources and collaborators to successfully pursue future independent studies.
Project Summary: Impaired metabolic signal transduction that mediates insulin secretion is fundamental in the pathophysiology of diabetes. Identification of valid targets for intervention in the treatment of diabetes requires knowledge of the metabolic signals that lead to stimulation of insulin secretion as well as its failure. This grant focuses on the roles of reactive oxygen species (ROS) as putative signals mediating glucose-stimulated insulin secretion (GSIS). There are two specific aims: (i) Test the hypothesis that ROS, in the low physiological range, are additional metabolic signals that regulate a cytosolic redox network to modulate insulin secretion; (ii) Test the hypothesis that antioxidant response mediated by transcription factor Nrf2 enhances cellular ROS scavenging activity and thus negatively regulates GSIS. The unique features of pancreatic (-cells, with relatively low expression and activity of many of antioxidant enzymes, provide a sensitive system for ROS/redox signaling. Importantly, the generation of ROS, which have emerged as physiological mediators of many cellular responses, is coupled to oxidative mitochondrial metabolism. We propose to (i) investigate the modulatory effect of glucose on intracellular ROS/redox signaling and the correlation with GSIS in INS-1 (832/13) cells and isolated intact mouse islets; (ii) evaluate the stimulation effects of ROS on insulin secretion and the inhibition effect of antioxidants on GSIS in these models; (iii) examine the effects of targeted gene disruption of Nrf2 or UCP2 on ROS/redox signaling and GSIS. Nrf2 is a central regulator in both constitutive and inducible gene expression of antioxidant enzymes, whereas UCP2 has been recognized as a negative regulator of mitochondria-derived ROS.
Relevance: This project will help to foster the development of a successful scientist specializing in diabetes research. His currently proposed and future studies will contribute new insights into the mechanisms of diabetes and hopefully advance preventive measures and treatment strategies for this disease.
描述(由申请人提供):
Jingbo Pi博士的长期目标是成为糖尿病研究领域的成功独立研究者。 PI博士的大部分时间都将花在他在他对活性氧物种的提议中所描述的研究项目上,并且(-Cell功能(以下在项目摘要中进行了摘要)。这一经验将为他提供理论和实践知识的基础,以在该领域建立一个独立研究者的职业,这是他职业发展计划的主要研究。口头和(iii)授予技巧的科学表现卓越,以及如何最好地组织必要的资源和合作者,以成功地追求未来的独立研究。
项目摘要:介导胰岛素分泌的代谢信号转导受损是糖尿病病理生理学的基础。确定干预糖尿病治疗的有效靶标需要了解导致胰岛素分泌及其失败的代谢信号。该赠款的重点是活性氧(ROS)作为介导葡萄糖刺激的胰岛素分泌(GSIS)的推定信号。有两个具体的目的:(i)检验以下假设:在低生理范围内的ROS是调节胞质氧化还原网络以调节胰岛素分泌的其他代谢信号; (ii)检验以下假设:转录因子NRF2介导的抗氧化剂反应增强了细胞ROS清除活性,从而对GSI进行负调节。胰腺的独特特征( - 许多抗氧化剂的表达和活性相对较低,为ROS/REDOX信号传导提供了一个敏感的系统。重要的是,重要的是,ROS的产生已作为许多细胞反应的生理介导者出现,以氧化为氧化的线粒体启用氧化代码。 ROS/REDOX信号与INS-1(832/13)细胞中的GSIS和孤立的小鼠胰岛的相关性评估ROS对胰岛素分泌的刺激作用,抗氧化剂对GSI的抑制作用对这些模型的抑制作用(III)。抗氧化酶的本构和诱导基因表达中的调节剂,而UCP2被认为是线粒体衍生的ROS的负调节剂。
相关性:该项目将有助于促进专门研究糖尿病研究的成功科学家的发展。他目前提出的研究和未来的研究将为糖尿病的机制提供新的见解,并希望推动对该疾病的预防措施和治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jingbo Pi其他文献
Jingbo Pi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jingbo Pi', 18)}}的其他基金
Paradoxical roles of Nrf2 activation in arsenic-induced beta-cell dysfunction
Nrf2 激活在砷诱导的 β 细胞功能障碍中的矛盾作用
- 批准号:
8274435 - 财政年份:2008
- 资助金额:
$ 8.21万 - 项目类别:
Paradoxical roles of Nrf2 activation in arsenic-induced beta-cell dysfunction
Nrf2 激活在砷诱导的 β 细胞功能障碍中的矛盾作用
- 批准号:
8071225 - 财政年份:2008
- 资助金额:
$ 8.21万 - 项目类别:
Paradoxical roles of Nrf2 activation in arsenic-induced beta-cell dysfunction
Nrf2 激活在砷诱导的 β 细胞功能障碍中的矛盾作用
- 批准号:
7686956 - 财政年份:2008
- 资助金额:
$ 8.21万 - 项目类别:
Paradoxical roles of Nrf2 activation in arsenic-induced beta-cell dysfunction
Nrf2 激活在砷诱导的 β 细胞功能障碍中的矛盾作用
- 批准号:
7540646 - 财政年份:2008
- 资助金额:
$ 8.21万 - 项目类别:
Paradoxical Roles of Reactive Oxygen Species in Pancreatic Beta-Cell Function
活性氧在胰腺 β 细胞功能中的矛盾作用
- 批准号:
7446068 - 财政年份:2007
- 资助金额:
$ 8.21万 - 项目类别:
Paradoxical Roles of Reactive Oxygen Species in Pancreatic Beta-Cell Function
活性氧在胰腺 β 细胞功能中的矛盾作用
- 批准号:
7316452 - 财政年份:2007
- 资助金额:
$ 8.21万 - 项目类别:
Paradoxical Roles of Reactive Oxygen Species in Pancreatic Beta-Cell Function
活性氧在胰腺 β 细胞功能中的矛盾作用
- 批准号:
7809167 - 财政年份:2007
- 资助金额:
$ 8.21万 - 项目类别:
相似国自然基金
跨区域调水工程与区域经济增长:效应测度、机制探究与政策建议
- 批准号:72373114
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
农产品区域公用品牌地方政府干预机制与政策优化研究
- 批准号:72373068
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
新型城镇化与区域协调发展的机制与治理体系研究
- 批准号:72334006
- 批准年份:2023
- 资助金额:167 万元
- 项目类别:重点项目
我国西南地区节点城市在次区域跨国城市网络中的地位、功能和能级提升研究
- 批准号:72364037
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
多时序CT联合多区域数字病理早期预测胃癌新辅助化疗抵抗的研究
- 批准号:82360345
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Zinc Protection Against Ischemia-Reperfusion Injury in Heart
锌可预防心脏缺血再灌注损伤
- 批准号:
10652915 - 财政年份:2023
- 资助金额:
$ 8.21万 - 项目类别:
The Role of Adenine Nucleotide Translocase in Mitochondrial Dysfunction Associated Senescence in Chronic Obstructive Pulmonary Disease (COPD)
腺嘌呤核苷酸转位酶在慢性阻塞性肺病(COPD)线粒体功能相关衰老中的作用
- 批准号:
10633608 - 财政年份:2023
- 资助金额:
$ 8.21万 - 项目类别:
Endothelial Cell Respiration in Atherosclerotic Plaque Erosion
动脉粥样硬化斑块糜烂中的内皮细胞呼吸
- 批准号:
10586227 - 财政年份:2023
- 资助金额:
$ 8.21万 - 项目类别:
Islet encapsulation to elicit localized immunosuppression and immune modulation following transplantation
移植后胰岛封装引发局部免疫抑制和免疫调节
- 批准号:
10667778 - 财政年份:2023
- 资助金额:
$ 8.21万 - 项目类别: